1. Dagci AOB, Cushing KC. Genetic defects in early-onset inflammatory bowel disease. Rheum Dis Clin N Am 2023; 49: 861-74.
2.
Bouhuys M, Lexmond WS, van Rheenen PF. Pediatric inflammatory bowel disease. Pediatrics 2022; 151: e2022058037.
3.
Turner D, Ruemmele FM, Orlanski-Meyer E, et al. Management of paediatric ulcerative colitis. Part 1. J Pediatr Gastroenterol Nutr 2018; 67: 257-91.
4.
Grover Z, Biron R, Carman N, et al. Predictors of response to Infliximab in children with luminal Crohn’s disease. J Crohns Colitis 2014; 8: 739-46.
5.
Menon T, Afzali A. Inflammatory bowel disease: a practical path to transitioning from pediatric to adult care. Am J Gastroenterol 2019; 114: 1432-40.
6.
Bay MC, Núñez FP, Quera R, et al. Current perspectives on pediatric inflammatory bowel disease focusing on transitional care management. What should we consider? Gastroenterol Hepatol Engl Ed 2023; 46: 139-47.
7.
Kuenzig ME, Fung SG, Marderfeld L, et al. Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review. Gastroenterology 2022; 162: 1147-59.e4.
8.
Philpott JR, Kurowski JA. Challenges in transitional care in inflammatory bowel disease: a review of the current literature in transition readiness and outcomes. Inflamm Bowel Dis 2019; 25: 45-55.
9.
van Rheenen PF, Aloi M, Biron IA, et al. European Crohn’s and Colitis Organisation topical review on transitional care in inflammatory bowel disease. J Crohns Colitis 2017; 11: 1032-8.
10.
Tan B, Ong D. Pediatric to adult inflammatory bowel disease transition: the Asian experience. Intest Res 2020; 18: 11-7.
11.
Baldassano R, Ferry G, Griffiths A, et al. Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2002; 34: 245-8.
12.
Vernon-Roberts A, Chan P, Christensen B, et al. Pediatric to adult transition in inflammatory bowel disease: consensus guidelines for Australia and New Zealand. Inflamm Bowel Dis 2024; 31: 563-8.
13.
Castiglione F, Scarallo L, Nardone OM, et al. Transition care in patients with IBD: The pediatric and the adult gastroenterologist’s perspective. Results from a national survey. Dig Liver Dis 2024; 56: 802-9.
14.
Kaul K, Schumann S, Sander C, et al. Health literacy of children and adolescents with inflammatory bowel disease (IBD) and parents of IBD patients – coping and information needs. Children 2024; 11: 481.
15.
Sánchez Sánchez C, Tolín Hernani MDM, Álvarez Calatayud G, et al. Status of transition care in inflammatory bowel disease in Spain. Different medical perspectives. Rev Esp Enfermedades Dig 2019; 111: 833-8.
16.
Vernon-Roberts A, Chan P, Christensen B, et al. Transitional care of adolescents with inflammatory bowel disease to adult services varies widely across Australia and New Zealand. JGH Open Open Access J Gastroenterol Hepatol 2024; 8: e13032.
17.
Jawaid N, Jeyalingam T, Nguyen G, et al. Paediatric to adult transition of care in IBD: understanding the current standard of care among Canadian Adult Academic Gastroenterologists. J Can Assoc Gastroenterol 2019; 3: 266-73.
18.
Giouleme O, Koutsoumourakis A, Katsoula A, et al. Barriers to and requirements for a successful transition in inflammatory bowel disease from pediatric to adult care in Greece. Ann Gastroenterol 2023; 36: 541-8.
19.
Erős A, Veres G, Tárnok A, et al. A cross-sectional survey on the transitional care of adolescents with inflammatory bowel disease in Hungary. J Pediatr Nurs Nurs Care Child Fam 2020; 55: e279-85.
20.
Kumagai H, Kudo T, Uchida K, et al. Transitional care for inflammatory bowel disease: a survey of Japanese pediatric gastroenterologists. Pediatr Int 2021; 63: 65-71.
21.
Tóbi L, Prehoda B, Balogh AM, et al. Transition is associated with lower disease activity, fewer relapses, better medication adherence, and lower lost-to-follow-up rate as opposed to self-transfer in pediatric-onset inflammatory bowel disease patients: results of a longitudinal, follow-up, controlled study. Ther Adv Gastroenterol 2024; 17: 17562848241252947.
22.
Choukair D, Patry C, Lehmann R, et al. Resource utilization and costs of transitioning from pediatric to adult care for patients with chronic autoinflammatory and autoimmune disorders. Pediatr Rheumatol 2024; 22: 28.
23.
Schütz L, Radke M, Menzel S, et al. Long-term implications of structured transition of adolescents with inflammatory bowel disease into adult health care: a retrospective study. BMC Gastroenterol 2019; 19: 128.
24.
McCartney S, Lindsay JO, Russell RK, et al. Benefits of structured pediatric to adult transition in inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2022; 74: 208-14.
25.
Yoo EJ, Cho SH, Park SJ, et al. Characteristics and treatment outcomes of transition among patients with inflammatory bowel disease. Yonsei Med J 2023; 64: 541-8.
26.
Otto C, Tárnok A, Erős A, et al. Planned transition of adolescent patients with inflammatory bowel disease results in higher remission rates. J Pediatr Nurs Nurs Care Child Fam 2019; 45: 62-6.
27.
Rubín de Célix C, Martín-de-Carpi J, Pujol-Muncunill G, et al. Benefits of paediatric to adult transition programme in inflammatory bowel disease: the BUTTERFLY Study of GETECCU and SEGHNP. J Clin Med 2023; 12: 4813.
28.
Li L, Feng X, Luo S, et al. Internet addiction and health-related quality of life in adolescents: the mediating role of sleep disturbance. Sleep Med 2024; 117: 53-9.
29.
Khan SM, Tuchman D, Imran A, et al. A Smooth transition: assessing transition readiness in adolescents with inflammatory bowel disease. Dig Dis Sci 2024; 69: 3640-9.
30.
Park J, Park S, Lee SA, et al. Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management. Korean J Intern Med 2021; 36: 1040-8.
